Dr Reddys Laboratories (RDY) Cash & Current Investments (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Cash & Current Investments of $118.35 million for the quarter ended Jun 30, 2026, up 12.5% from $105.21 million a year earlier but down 71.2% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Cash & Current Investments (2009 - 2026) Analysis & Trends
As of Mar 31, 2026, Dr Reddys Laboratories' Cash & Current Investments came in at $416.15 million, up 98.9% from the prior year.
- Annual Cash & Current Investments shows a five-year compound annual growth rate of 12.8% (years ended Mar 2021 to Mar 2026).
- In prior years, Dr Reddys Laboratories' Cash & Current Investments was $209.17 million in the year ended Mar 31, 2025 (-41.4%), $357.13 million in the year ended Mar 31, 2024 (-53.1%), $761 million in the year ended Mar 31, 2023 (+271.9%) and $204.62 million in the year ended Mar 31, 2022 (-10.3%).
- Quarterly Cash & Current Investments has run from a low of $58.9 million in the quarter ended Jun 30, 2024 to a high of $759.77 million in the quarter ended Mar 31, 2023 over five years.
- On a year-over-year basis, Cash & Current Investments has increased in each of the last three quarters, with growth averaging 27.1% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was the quarter ended Mar 31, 2022, with growth of 292.5%; the weakest was the quarter ended Jun 30, 2024, with a decline of 92.1%.
- According to Business Quant data, Cash & Current Investments for the three prior quarters was $411.56 million (quarter ended Mar 31, 2026), $209.51 million (quarter ended Dec 31, 2025) and $113.57 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Dr Reddys Laboratories | 10.22 Bn | 9.41 Bn | 396.53 Mn | 118.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 118.35 Mn |
| Mar 31, 2026 | 411.56 Mn |
| Dec 31, 2025 | 209.51 Mn |
| Sep 30, 2025 | 113.57 Mn |
| Jun 30, 2025 | 105.21 Mn |
| Mar 31, 2025 | 205.51 Mn |
| Dec 31, 2024 | 154.35 Mn |
| Sep 30, 2024 | 135.27 Mn |
| Jun 30, 2024 | 58.90 Mn |
| Mar 31, 2024 | 340.85 Mn |
| Dec 31, 2023 | 90.49 Mn |
| Sep 30, 2023 | 180.73 Mn |
| Jun 30, 2023 | 745.00 Mn |
| Mar 31, 2023 | 759.77 Mn |
| Dec 31, 2022 | 76.23 Mn |
| Sep 30, 2022 | 120.76 Mn |
| Jun 30, 2022 | 432.00 Mn |
| Mar 31, 2022 | 205.63 Mn |
| Dec 31, 2021 | 293.30 Mn |
| Sep 30, 2021 | 163.30 Mn |
API Access
Dr Reddys Laboratories Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();